New rapid acting meal time Insulin to treat Type 1 Diabetes

Study Closed

Type of Study:

Adult Type 1

Title of Study:

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D

Short Title:

New rapid acting meal time Insulin to treat Type 1 Diabetes

Study Length: 65 Weeks

Target Age/Sex: 18+, Male and Female

Benefits:

Participants will receive at no cost: Study medication, study related supplies, study related lab work and medical exams. Subject will also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov